Teva Pharmaceutical Industries (TEVA) Consolidated Net Income (2009 - 2026)
Teva Pharmaceutical Industries (TEVA) posted Consolidated Net Income of -$575 million for Q2 2026, compared with $283 million a year earlier.
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) Consolidated Net Income (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Consolidated Net Income at Teva Pharmaceutical Industries was $709 million; for FY2025, it came in at $1.42 billion.
- In prior years, Teva Pharmaceutical Industries' Consolidated Net Income was -$1.96 billion in FY2024, -$615 million in FY2023, -$2.5 billion in FY2022 and $456 million in FY2021.
- The Q2 2026 figure stands as the lowest quarterly Consolidated Net Income since Q2 2024.
- According to Business Quant data, Consolidated Net Income for the three prior quarters was $369 million (Q1 2026), $481 million (Q4 2025) and $434 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | -237.00 Mn |
| 10 | Teva Pharmaceutical Industries | 45.83 Bn | 32.68 Bn | 2.15 Bn | -575.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -575.00 Mn |
| Mar 31, 2026 | 369.00 Mn |
| Dec 31, 2025 | 481.00 Mn |
| Sep 30, 2025 | 434.00 Mn |
| Jun 30, 2025 | 283.00 Mn |
| Mar 31, 2025 | 220.00 Mn |
| Dec 31, 2024 | -275.00 Mn |
| Sep 30, 2024 | -390.00 Mn |
| Jun 30, 2024 | -874.00 Mn |
| Mar 31, 2024 | -419.00 Mn |
| Dec 31, 2023 | 467.00 Mn |
| Sep 30, 2023 | 77.00 Mn |
| Jun 30, 2023 | -906.00 Mn |
| Mar 31, 2023 | -253.00 Mn |
| Dec 31, 2022 | -1.33 Bn |
| Sep 30, 2022 | 63.00 Mn |
| Jun 30, 2022 | -278.00 Mn |
| Mar 31, 2022 | -952.00 Mn |
| Dec 31, 2021 | -152.00 Mn |
| Sep 30, 2021 | 302.00 Mn |
API Access
Teva Pharmaceutical Industries Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=TEVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "TEVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=TEVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();